[go: up one dir, main page]

AU2003258942A1 - Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors - Google Patents

Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors

Info

Publication number
AU2003258942A1
AU2003258942A1 AU2003258942A AU2003258942A AU2003258942A1 AU 2003258942 A1 AU2003258942 A1 AU 2003258942A1 AU 2003258942 A AU2003258942 A AU 2003258942A AU 2003258942 A AU2003258942 A AU 2003258942A AU 2003258942 A1 AU2003258942 A1 AU 2003258942A1
Authority
AU
Australia
Prior art keywords
imidazolidinedione
derivatives
metalloproteinase inhibitors
metalloproteinase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003258942A
Inventor
David Chapman
Anders Eriksson
Anna Kristoffersson
Igor Shamovsky
Kristina Stenvall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2003258942A1 publication Critical patent/AU2003258942A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003258942A 2002-09-11 2003-09-10 Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors Abandoned AU2003258942A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0202693-8 2002-09-11
SE0202693A SE0202693D0 (en) 2002-09-11 2002-09-11 Compounds
PCT/SE2003/001407 WO2004024718A1 (en) 2002-09-11 2003-09-10 Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors

Publications (1)

Publication Number Publication Date
AU2003258942A1 true AU2003258942A1 (en) 2004-04-30

Family

ID=20288963

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003258942A Abandoned AU2003258942A1 (en) 2002-09-11 2003-09-10 Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors

Country Status (3)

Country Link
AU (1) AU2003258942A1 (en)
SE (1) SE0202693D0 (en)
WO (1) WO2004024718A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100902D0 (en) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (en) 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
SE0202539D0 (en) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
SE0401763D0 (en) * 2004-07-05 2004-07-05 Astrazeneca Ab Compounds
PE20060748A1 (en) * 2004-09-21 2006-10-01 Smithkline Beecham Corp INDOLCARBOXAMIDE DERIVATIVES AS KINASE INHIBITORS IKK2
SE0403085D0 (en) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
SE0403086D0 (en) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
TW200740769A (en) 2006-03-16 2007-11-01 Astrazeneca Ab Novel process
AU2007307990A1 (en) 2006-10-05 2008-04-17 Janssen Pharmaceutica, N.V. Heterocyclic derived metalloprotease inhibitors
WO2009007747A2 (en) * 2007-07-11 2009-01-15 Astrazeneca Ab Hydantoin derivatives used as mmp12 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1191024A1 (en) * 2000-09-22 2002-03-27 Harald Tschesche Thiadiazines and their use as inhibitors of metalloproteinases
SE0100902D0 (en) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
CZ20032502A3 (en) * 2001-03-15 2004-01-14 Astrazeneca Ab Metalloproteinase inhibitors

Also Published As

Publication number Publication date
WO2004024718A1 (en) 2004-03-25
SE0202693D0 (en) 2002-09-11

Similar Documents

Publication Publication Date Title
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003263345A1 (en) Sulphonamide derivatives and their use as tace inhibitors
AU2003221786A1 (en) Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
AU2003303128A1 (en) Inhibitors and methods of use thereof
AU2003255376A1 (en) Piperidine-derivatives as pde4 inhibitors
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
PL373146A1 (en) Pyridazinone-derivatives as pde4 inhibitors
AU2003249531A1 (en) Azaisoquinoline derivatives as matrix metalloproteinase inhibitors
AU2003232848A1 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
AU2003249477A1 (en) Heterobicylcic metalloproteinase inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
AU2003215756A1 (en) Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
PL374581A1 (en) Diaminothiazoles and use thereof as cdk4 inhibitors
AU2003230392A1 (en) Beta-secretase inhibitors
AU2003299901A1 (en) Thrombin inhibitors
AU2003258942A1 (en) Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors
IL164898A0 (en) Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors
AU2003298810A1 (en) NF-kB INHIBITORS AND USES THEREOF
AU2003269984A1 (en) Protease inhibitors
AUPS282002A0 (en) Metalloproteinase inhibitors
AU2003211520A1 (en) Lfa-1 inhibitors and use thereof
AU2003258941A1 (en) Metalloproteinase inhibitors and intermediates for preparation thereof
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003218715A1 (en) Azepane derivatives and their use as atk1 inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase